Sunday, September 25, 2022

Amazon's Nearly $5 Million, On Lobbying In Q2 2022... Was Spent On These Issues (Among Others)...


This concludes the data set -- for the bar chart, at right. On a quiet Sunday, it seems. . . fitting. But it is very much a partial listing.

That is, to be clear, the company lobbied on many more issues and bills, but I've culled out the ones related to public health, STEM and the life sciences -- as well as US health care delivery (you may search at Senate.gov, under "Legislation and Records", then under "Public Disclosures", and then in the LDA databases, for "Amazon" and then sort for latest data, first -- if you want to see page after page of detail --as to where the company's money went):

. . .Issues related to immigration, high-skilled immigration, and non-immigrant visas, including issues related to employment-based visas, green card recapture, the STEM visa exemption provision, the DREAM Act (S. 264), the EAGLE Act (H.R. 3648), the American Dream and Promise Act (H.R. 6), the Build Back Better Act (H.R. 5736), the United States Innovation and Competition Act of 2021 (H.R. 4521/S. 1260), and Deferred Action for Childhood Arrivals (DACA). . . .

Issues related to US trade policy, including USMCA, the World Trade Organization, the World Customs Organization, China, country of origin labeling, US customs policy and procedures, US tariffs, foreign direct investment, issues related to domestic semiconductor manufacturing and research, export controls, sanctions, and supply chain, and other trade practices, including in the EU, Asia, and Latin America, including the National Defense Authorization Act for Fiscal Year 2023 (H.R. 7900), the United States Innovation and Competition Act of 2021 (S. 1260), America COMPETES Act of 2022 (H.R. 4521), EAGLE Act (H.R. 3524), the COOL Online Act (S. 3707), A bill to amend the Tariff Act of 1930 to enhance the authority of U.S. Customs and Border Protection to share information with respect to merchandise suspected of violating intellectual property rights with rights holders and other interested parties (S. 1159), and Federal Contracting for Peace and Security Act (H.R. 7185). . . .

Issues related to USDA SNAP online purchasing, Electronic Benefit Transfer, the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), the Commodity Supplemental Food Program, food safety, infant formula shortage, and the White House Conference on Food Nutrition Hunger and Health Act (H.R. 5724/S. 3064). . . .

Issues related to veterans hiring and training, employee compensation and benefits, workplace safety, competition, and minimum wage, including the Raise the Wage Act (H.R. 603 / S. 53), the Pregnant Workers Fairness Act (H.R. 1065/S. 1486), the American Choice and Innovation Online Act of 2021 (H.R. 3816), Platform Competition and Opportunity Act of 2021 (H.R. 3826), Ending Platform Monopolies Act of 2021 (H.R. 3825), ACCESS Act of 2021 (H.R. 3849), the Competition and Antitrust Law Enforcement Reform Act of 2021 (S. 225), the Platform Competition and Opportunity Act of 2021 (S. 3197), and the American Innovation and Choice Online Act (S. 2992). . . .

Issues related to health care, including employee health care plans, HIPAA, health information technology, telehealth, including the Consolidated Appropriations Act, 2022 (Public Law 117-103), the Telehealth Modernization Act (H.R. 1332 / S. 368), the CONNECT Act (H.R. 2903 / S. 1512), the Telehealth Expansion Act (S. 1704), and the Ensuring Telehealth Expansion Act (H.R. 341), the Cures 2.0 Act (H.R. 6000), and the Food and Drug Amendments Act of 2023 (H.R. 7667), the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S. 4348), and the Prescription Information Modernization Act of 2022 (H.R. 7559). Issues related to pharmacy, vaccines, and COVID-19 testing, including implementation of the CARES Act (Public Law 116-136). . . .


Now you know. Out, smiling -- even if this is deeply delayed. We will have Q3 disclosures for all these companies -- in about a month's time here.

नमस्ते

No comments: